AnalystsDylan DupuisDylan Dupuis's Stock Forecasts
AnalystsDylan Dupuis
Sectors:
Industries:
Analyst Ranking
Top 33%
#1606 out of 4872 analysts
Average Return
+7.87%
Win Rate
27%3 out of 11
Risk vs Reward
Poor
Good
Dylan Dupuis's 5 best and worst ratings
Dylan Dupuis Analyst Color
Get additional color on Dylan Dupuis's coverage of popular stocks
Dylan Dupuis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Chemomab Therapeutics LtdCMMB | 2 | Strong Buy | $7.00 | N/A | Reinstates | a year ago |
Inventiva SaIVA | 2 | Strong Buy | $11.00 | N/A | Reiterates | 2 years ago |
Aslan Pharmaceuticals LtdASLN | 2 | Strong Buy | $120.00 | N/A | Reiterates | 2 years ago |
Terns Pharmaceuticals IncTERN | 3 | Strong Buy | $23.00 | N/A | Reiterates | 2 years ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $32.00 | N/A | Assumes | 2 years ago |
Unity Biotechnology IncUBX | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.